Andong Guo

机构：Shandong Provincial Hospital, Shandong First Medical University

发表论文 10 篇 · 总被引 29 次 · h-index 3

代表论文

• Expression of HER2 in high-grade urothelial carcinoma based on Chinese expert consensus and the clinical effects of disitamab vedotin-tislelizumab combination therapy in the treatment of advanced patients (2024 · Frontiers in Pharmacology · 被引 17)
• Expression of HER2 in urothelial carcinoma and its significance (2024 · Current Urology · 被引 4)
• Effect of everolimus and gefitinib on PI3K/akt/mTOR and raf/MEK/ERK pathways in NSCLC cells. (2010 · Journal of Clinical Oncology · 被引 4)
• Association between sex steroid hormones and α-klotho: Results from the NHANES 2013-2016 and Mendelian randomization study (2025 · Experimental Gerontology · 被引 3)
• Uric acid mediates the association between testosterone and α-Klotho among males: results from the NHANES 2013–2016 (2024 · International Urology and Nephrology · 被引 1)
• The impact of different formulations and dosing intervals of goserelin on testosterone suppression in patients with prostate cancer: A real-world observational study. (2026 · Journal of Clinical Oncology)